Fundación Unión para el Control del Cáncer-Unicáncer
Fundación Unión para el Control del Cáncer-Unicáncer is a non-profit healthcare IPS in Cali, Colombia, affiliated with Liga Colombiana contra el Cáncer, providing cancer prevention, early detection, diagnostic, treatment, and palliative care services to individual patients and vulnerable communities through a single facility, on-site pharmacy, and community outreach programs.
- Company typePrivate
- Founded-
- HeadquartersSantiago de Cali, Colombia
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Fundación Unión para el Control del Cáncer-Unicáncer does
Fundación Unión para el Control del Cáncer-Unicáncer (Unicancer Cali) is a non-profit healthcare foundation (IPS) established in 1950 and headquartered in Cali, Valle del Cauca, Colombia, operating as the Valle seccional chapter of the Liga Colombiana contra el Cáncer. The organization provides a comprehensive range of cancer-related healthcare services, including diagnostic support (mammography, stereotactic and vacuum-assisted biopsy, HPV testing, ultrasound, pathology, densitometry), outpatient consultations across twelve specialties (general medicine, integrative medicine, nutrition, psychology, palliative care, gynecology, urology, dermatology, family medicine, mastology), therapeutic support (chemotherapy, infusion therapy, ultrasound-guided pain blocks), and a comprehensive palliative support program (SIP) based on the New Palex Method. The institution also operates an on-site pharmacy dispensing oncology medications, pain management drugs, HIV medications, dietary supplements, and 16 bioregulator products, and runs community programs including Mujeres U (women's health) and Cuidamos de Ti (patient wellness).
Unicancer generates revenue through three streams: fee-for-service healthcare delivery (diagnostic tests, consultations, chemotherapy), pharmacy product sales, and donations and fundraising (including condolence bonds "Bonos Luz de Esperanza" starting at $70,000 COP and awareness bracelets from $6,000 COP). The go-to-market approach is community-led, relying on educational campaigns, partnerships with NGOs, universities, government agencies, and corporations, and outreach to schools and vulnerable communities. WhatsApp serves as the primary appointment scheduling channel, and patients can access results online through dedicated portals. The organization is ISO 9001:2015 certified (ICONTEC assessment dated September 14, 2022) for quality management in diagnostic support and early cancer detection services.
The organization maintains an extensive partnership ecosystem that includes collaborations with Fundación AVON (breast cancer screening), Secretaría de Salud de Cali and Alcaldía de Cali (HPV vaccination campaigns), La Roche-Posay (skin cancer screening), Universidad Javeriana Cali (education and awareness), Instituto PIO (nursing training), Sonoco (corporate wellness), and multiple NGOs for community outreach. The entity is a private non-profit with 22 employees, a single headquarters location, and no disclosed funding rounds, acquisitions, or M&A activity.
Fundación Unión para el Control del Cáncer-Unicáncer firmographics
Firmographics- Name
- Fundación Unión para el Control del Cáncer-Unicáncer
- Legal name
- Fundación Unión para el Control del Cáncer-Unicancer
- Website
- https://unicancercali.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Fundación Unión para el Control del Cáncer-Unicáncer is a non-profit healthcare IPS in Cali, Colombia, affiliated with Liga Colombiana contra el Cáncer, providing cancer prevention, early detection, diagnostic, treatment, and palliative care services to individual patients and vulnerable communities through a single facility, on-site pharmacy, and community outreach programs.
- Ownership category
- akta.pro rank
Fundación Unión para el Control del Cáncer-Unicáncer industry classification
Industry- Product category
- Oncology Healthcare Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)
- akta.pro secondary industries
- Urologic Oncology (HLAKAOAB), Gynecologic Oncology (HLAKAJAD)
Keywords
Where Fundación Unión para el Control del Cáncer-Unicáncer is headquartered
LocationHeadquarters
- HQ city
- Santiago de Cali
- HQ country
- Colombia
- HQ region
- Latin America
Offices1 record
Markets served
Fundación Unión para el Control del Cáncer-Unicáncer business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D
Revenue model
- Healthcare Services: Fee-for-service healthcare delivery including diagnostic tests (mammography, biopsies, cytology, ultrasound), medical consultations across multiple specialties, chemotherapy administration, and other clinical services provided to patients.
- Pharmacy Sales: Retail sale of medications including oncology drugs, pain management medications, biorregulators, dietary supplements, and personal care products through their on-site pharmacy.
- Donations and Fundraising: Acceptance of donations from individuals and organizations to support cancer prevention and early detection programs. Sale of solidarity products such as condolence bonds (Bonos Luz de Esperanza) and awareness bracelets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Pharmacy products including specialized oncology medications |
| Other | Pay-as-you-go | Donation and solidarity products |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Fundación Unión para el Control del Cáncer-Unicáncer product offering
Product offeringCore offering
Unicancer is an oncology-focused healthcare IPS providing cancer prevention, early detection, diagnosis, treatment, and palliative care services. Its offerings include diagnostic imaging (mammography, ultrasound, stereotactic and vacuum-assisted biopsy, densitometry), laboratory pathology and cytology, outpatient consultations across 12 specialties, chemotherapy and infusion therapy, ultrasound-guided pain blocks, a New Palex Method-based palliative support program (SIP), and an on-site pharmacy dispensing oncology medications, pain drugs, bioregulators, and HIV medications.
Product overview
Unicancer Cali is a healthcare institution providing comprehensive cancer prevention, early detection, and treatment services. The organization operates as a multi-service oncology center offering diagnostic support services (cytology, HPV testing, mammography, ultrasound, biopsies, pathology, densitometry), outpatient consultations across 12 specialties (general medicine, integrative medicine, nutrition, psychology, social work, dermatology, palliative care, gynecology, urology, mastology, family medicine), therapeutic support (chemotherapy, infusion therapy, ultrasound-guided pain blocks), a palliative support program (SIP), and an on-site pharmacy. The pharmacy provides oncology medications, pain management drugs, dietary supplements, bioregulators (16 products including ARANEA D8, ARTHREXAN, VISCUM A D17, DIGEZIMES, L-GLUTATHIONE, OSEOMASS), and specialized medications (11 products including RECORMON, PROLIA, METOTREXATO, Filgrastim, Pegfilgrastim). Additional services include the Mujeres U community wellness program, patient wellness initiatives, and online result delivery portals. The institution maintains ISO 9001:2015 certification for quality management.
Differentiator
Problem solved
Functional benefit
Brands
- Mujeres U: A community program focused on women's health education, body awareness, and informed decision-making about women's health.
- SIP - Programa Soporte Integral Paliativo
- Programa Soporte Integral Paliativo (SIP)
Products and services
- Apoyo Diagnóstico (Diagnostic Support Services) Multi-modality diagnostic imaging and laboratory services for cancer detection, including vaginal and anal cytology (Pap smears), HPV testing, conventional/obstetric/Doppler ultrasound, mammography with stereotactic and vacuum-assisted biopsy, conventional and ultrasound-guided biopsy, bone densitometry, pathology, diagnostic procedures in gynecology, urology, and dermatology, and hematology. Targeted at patients referred for cancer screening and diagnostic confirmation.
- Consulta Externa (Outpatient Specialty Consultations) Outpatient medical consultations across general medicine, integrative medicine, nutrition and dietetics, family medicine, psychology, social work, dermatology, pain management and palliative care, gynecology and obstetrics, urology, the Mastology Program, and oncological dermatology. Targeted at patients requiring primary care, specialty assessment, and supportive counseling related to cancer risk and treatment.
- Apoyo Terapéutico (Therapeutic Support) Therapeutic services including chemotherapy administration, intravenous fluid therapy (sueroterapia), an infusion room, and ultrasound-guided pain blocks for chronic pain management. Targeted at oncology patients in active treatment and patients requiring palliative pain control.
- Programa Soporte Integral Paliativo (SIP) Comprehensive palliative support program providing active, integral care to improve quality of life and physical, emotional, spiritual, and social well-being of oncology and non-oncology patients, operating under the New Palex Method of service excellence. Targeted at patients with advanced illness and their families.
- Farmacia Unicancer (On-Site Pharmacy) Retail pharmacy dispensing oncology medications, pain management drugs, dietary supplements and bioregulators (e.g., ARANEA D8, ARTHREXAN, CHINA O D18, COFFEA C D12, DIGEZIMES, EGALIV, FLORAWELL, IMBIOTICS, L-GLUTATHIONE, MAG X3, NYPERIM, OSEOMASS, OSTEOWELL, VISCUM A D17, ZIROCOL), HIV medications, and specialized oncology drugs (Azatioprina, Decapeptyl, Ferinjet, Firmagon, Megara, Metotrexato, Micofenolato, Neupogen, Pegfeel, Prolia, Recormon). Targeted at oncology patients and walk-in retail customers.
- Programa Mujeres U Community education program focused on women's body awareness, wellness care, and informed health decisions related to cancer prevention. Targeted at women in Cali and surrounding communities.
- Portales de Descarga de Resultados (Online Diagnostic Results Portals) Online portals allowing patients to download pathology, cytology, and other diagnostic results (internal portal) and mammography results (VisualMedica platform). Targeted at Unicancer patients seeking remote access to diagnostic reports.
Quantifiable outcome
- 98% survival rate when breast cancer is detected early
- +1 more outcomes
Companies that use Fundación Unión para el Control del Cáncer-Unicáncer
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles2 records
Fundación Unión para el Control del Cáncer-Unicáncer technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Fundación Unión para el Control del Cáncer-Unicáncer partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor and core.
- Instituto PIOminorEducational partnership for training nursing assistants in cancer prevention and early detection. Unicancer provided training to two groups of nursing students on gastric cancer awareness.
- La Roche-PosayminorPartnership in TOUR SALVA TU PIEL MOVIL 2023, a mobile skin cancer screening and prevention campaign. La Roche-Posay contributed to skin cancer awareness and early detection activities.
- Universidad Javeriana CalicoreOngoing collaboration including youth education forums (e.g., 'Inteligencia colectiva por los menores de edad expuestos al vapeo'), prostate cancer education campaigns, breast cancer awareness events, and recognition for three years of prevention commitment. Unicancer provided educational support and participated in university-hosted forums.
- Fundación AVONcoreNational alliance between Liga Colombiana contra el Cáncer (and all its seccionales including Unicancer Cali) and Fundación AVON for breast cancer awareness. AVON donated 1,000 mammograms nationally, with Unicancer Cali receiving 100 mammograms for vulnerable populations in the city. Joint awareness campaigns and education programs targeting at-risk communities.
- Secretaría de Salud de CalicorePartnership for Vacunatón #RegalodeVida campaign to vaccinate girls aged 9-17 against HPV (human papillomavirus) to prevent cervical cancer. The vaccination event was held at Unicancer facilities and at Parque de la Horqueta.
- Alcaldía de CalicoreMunicipal government partner in Vacunatón #RegalodeVida HPV vaccination campaign for cervical cancer prevention.
- SOSminorPartner organization in Vacunatón #RegalodeVida HPV vaccination campaign.
- Emisora BésameminorMedia partner for Vacunatón #RegalodeVida campaign, helping to promote the HPV vaccination event through radio broadcasts.
- Fundación Pazos InternacionalminorPartner in World Cancer Day event at Boulevar del Río, creating cancer awareness and providing information about prevention. Joint symbolic lighting ceremony for patients who died from cancer.
- Liga Colombiana contra el CáncercoreUnicancer operates as the Seccional Valle (Valley section) of Liga Colombiana contra el Cáncer, part of a national network of cancer prevention organizations. This affiliation provides operational framework, brand association, and national program coordination.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Fundación Unión para el Control del Cáncer-Unicáncer competitors and assessment
Company assessmentBroad incumbents
- Auna: Latin American healthcare network operating hospitals and outpatient clinics across multiple countries including Colombia. Overlapping oncology and multi-specialty capabilities, but with much broader geographic and service footprint.
- Compensar: Colombian social security and healthcare organization offering outpatient medical services, wellness programs, and community health education. Comparable in preventive health and community outreach focus, but with broader benefits portfolio.
- Keralty: Global healthcare organization with major Colombian operations through EPS Sanitas and clinic networks. Comparable as a healthcare provider in the same market but with vertically integrated payer-provider model.
Direct peers
- Hospital Universitario del Valle (HUV): Major public teaching hospital in Cali offering oncology and multi-specialty services. Directly comparable as a cancer-care provider in the same geographic market, though as a public tertiary hospital rather than community IPS.
- Instituto Nacional de Cancerología: Colombia's national cancer reference center providing oncology treatment, research, and prevention services. Directly comparable as a specialized cancer-care provider with overlapping mission, though federal in scale and scope.
- Fundación Santa Fe de Bogotá: Leading Colombian non-profit academic hospital offering comprehensive specialty care including oncology. Comparable as a high-quality non-profit healthcare institution with similar multi-specialty service model and academic affiliations.
- Profamilia: Colombian non-profit delivering reproductive and women's health services including cervical cancer screening (cytology, HPV testing). Closely comparable in women's cancer prevention mission and non-profit IPS operating model.
- Centro Médico Imbanaco: Leading private hospital in Cali offering comprehensive specialty care including oncology diagnostics and treatment. Comparable as a multi-specialty provider in the same city with overlapping diagnostic and outpatient service lines.
- Liga Colombiana contra el Cáncer (other seccionales): Other regional chapters of Unicancer's parent organization, running similar cancer prevention, screening, and IPS service models in other Colombian departments. Directly comparable operations, governance structure, and brand.
Others
- EPS Sura: Major Colombian health insurance company (EPS) that contracts oncology providers including screening and treatment services. Operates in the same healthcare ecosystem but as a payer rather than a provider.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Fundación Unión para el Control del Cáncer-Unicáncer social profiles
Digital presenceFundación Unión para el Control del Cáncer-Unicáncer compliance and trust
Trust signalCompliance1 record
Fundación Unión para el Control del Cáncer-Unicáncer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fundación Unión para el Control del Cáncer-Unicáncer leadership team
Management profileNumber of profiles
Profiles1 record
Fundación Unión para el Control del Cáncer-Unicáncer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fundación Unión para el Control del Cáncer-Unicáncer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fundación Unión para el Control del Cáncer-Unicáncer
What does Fundación Unión para el Control del Cáncer-Unicáncer do?
Unicancer is an oncology-focused healthcare IPS providing cancer prevention, early detection, diagnosis, treatment, and palliative care services. Its offerings include diagnostic imaging (mammography, ultrasound, stereotactic and vacuum-assisted biopsy, densitometry), laboratory pathology and cytology, outpatient consultations across 12 specialties, chemotherapy and infusion therapy, ultrasound-guided pain blocks, a New Palex Method-based palliative support program (SIP), and an on-site pharmacy dispensing oncology medications, pain drugs, bioregulators, and HIV medications.
Is Fundación Unión para el Control del Cáncer-Unicáncer a public or private company?
Fundación Unión para el Control del Cáncer-Unicáncer is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Fundación Unión para el Control del Cáncer-Unicáncer founded?
Fundación Unión para el Control del Cáncer-Unicáncer was founded in -1. It employs 11 to 50 people.
Where is Fundación Unión para el Control del Cáncer-Unicáncer based?
Fundación Unión para el Control del Cáncer-Unicáncer is headquartered in Santiago de Cali, Colombia, in the Latin America region.
How does Fundación Unión para el Control del Cáncer-Unicáncer make money?
Three revenue lines are on record. Healthcare Services are the primary driver. The others are pharmacy Sales and donations and Fundraising.
Who are Fundación Unión para el Control del Cáncer-Unicáncer's main competitors?
Broad incumbents on record are Auna, Compensar and Keralty. Direct peers are Hospital Universitario del Valle (HUV), Instituto Nacional de Cancerología, Fundación Santa Fe de Bogotá, Profamilia, Centro Médico Imbanaco and Liga Colombiana contra el Cáncer (other seccionales). EPS Sura is listed as an others.
Does Fundación Unión para el Control del Cáncer-Unicáncer have an API?
No public API is recorded for Fundación Unión para el Control del Cáncer-Unicáncer.
What industry is Fundación Unión para el Control del Cáncer-Unicáncer in?
Fundación Unión para el Control del Cáncer-Unicáncer's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAFAJAK, Gynecologic Oncology & Women’s Cancer Centers, with a secondary code of HLAKAOAB, Urologic Oncology. Its NAICS code is 62111 and its SIC code is 8011.